drugset / Trial / NCT00649831
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study compared the clinical efficacy and safety of azithromycin with that of amoxicillin-clavulanic acid, in patients between the ages of 35 and 75 years, presenting with an exacerbation of chronic bronchitis.
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Comparator | Azithromycin | Small molecule | 250 mg | Oral |
| Comparator | clavulinic acid | Unknown | 125 mg | Oral |